These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17885556)

  • 1. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
    Barton DA; Dawood T; Lambert EA; Esler MD; Haikerwal D; Brenchley C; Socratous F; Kaye DM; Schlaich MP; Hickie I; Lambert GW
    J Hypertens; 2007 Oct; 25(10):2117-24. PubMed ID: 17885556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover.
    Lambert EA; Schlaich MP; Dawood T; Sari C; Chopra R; Barton DA; Kaye DM; Elam M; Esler MD; Lambert GW
    J Physiol; 2011 May; 589(Pt 10):2597-605. PubMed ID: 21486790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing sympathetic overactivity in major depressive disorder.
    Hausberg M; Hillebrand U; Kisters K
    J Hypertens; 2007 Oct; 25(10):2004-5. PubMed ID: 17885539
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk.
    Dawood T; Lambert EA; Barton DA; Laude D; Elghozi JL; Esler MD; Haikerwal D; Kaye DM; Hotchkin EJ; Lambert GW
    Hypertens Res; 2007 Apr; 30(4):285-93. PubMed ID: 17541206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables.
    Alvarenga ME; Richards JC; Lambert G; Esler MD
    Psychosom Med; 2006; 68(1):8-16. PubMed ID: 16449406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomy of autonomic dysfunction in major depression.
    Koschke M; Boettger MK; Schulz S; Berger S; Terhaar J; Voss A; Yeragani VK; Bär KJ
    Psychosom Med; 2009 Oct; 71(8):852-60. PubMed ID: 19779146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.
    Mitchell DA; Lambert G; Secher NH; Raven PB; van Lieshout J; Esler MD
    J Physiol; 2009 Jun; 587(Pt 11):2589-97. PubMed ID: 19403604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks.
    Wilkinson DJ; Thompson JM; Lambert GW; Jennings GL; Schwarz RG; Jefferys D; Turner AG; Esler MD
    Arch Gen Psychiatry; 1998 Jun; 55(6):511-20. PubMed ID: 9633669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder.
    Baumert M; Lambert GW; Dawood T; Lambert EA; Esler MD; McGrane M; Barton D; Nalivaiko E
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H962-H968. PubMed ID: 18599596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
    Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
    Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
    Brunner-La Rocca HP; Esler MD; Jennings GL; Kaye DM
    Eur Heart J; 2001 Jul; 22(13):1136-43. PubMed ID: 11428854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder.
    Esler M; Alvarenga M; Barton D; Jennings G; Kaye D; Guo L; Schwarz R; Lambert G
    Front Psychiatry; 2022; 13():818012. PubMed ID: 35722546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder.
    Baumert M; Lambert GW; Dawood T; Lambert EA; Esler MD; McGrane M; Barton D; Sanders P; Nalivaiko E
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H674-9. PubMed ID: 19502559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors.
    Esler MD; Thompson JM; Kaye DM; Turner AG; Jennings GL; Cox HS; Lambert GW; Seals DR
    Circulation; 1995 Jan; 91(2):351-8. PubMed ID: 7805237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuronal noradrenaline transporter, anxiety and cardiovascular disease.
    Esler M; Alvarenga M; Pier C; Richards J; El-Osta A; Barton D; Haikerwal D; Kaye D; Schlaich M; Guo L; Jennings G; Socratous F; Lambert G
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):60-6. PubMed ID: 16785272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension.
    Esler M; Lambert G; Esler D; Ika Sari C; Guo L; Jennings G
    J Hypertens; 2020 Aug; 38(8):1488-1495. PubMed ID: 32195820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
    Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
    Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
    Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.